))
The Digital Therapeutics Alliance (DTA): From Principles to Practice | with ED Megan Coder
Manage episode 311600044 series 3151329
Content provided by Dorian Murariu. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dorian Murariu or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Digital therapeautics (DTx) are clinical intervention delivered as software that can help with medical ailments as wide ranging as asthma, epilepsy, IBS, depression, diabetes, arthritis, among many other conditions.
Why do we bring this up now? A handful of DTx companies have been around for about a decade or so, but the pandemic has accelerated the development and release of these therapies, increased awareness among legislators and sparked talks among regulatory and reimbursement agencies to establish global standards for assessing safety, efficacy and cost-effectiveness. If national programs are established to cover the cost of DTx and to create guidelines for prescribing DTx, this could have huge implications for healthcare systems, population health and especially for expanding access to under-served people, such as those living in rural areas.
In this episode I spoke with Megan about how the Digital Therapeutics Alliance (DTA), a non-profit trade association with roots in at least 15 countries, is helping to advance DTx. Their mission is to “broaden the understanding, adoption and integration of clinically evaluated digital therapeutics” among key healthcare stakeholders.
We hope you learn something from this talk – we sure did!
Check out the full video episode on our Youtube Channel: https://youtu.be/yVw7kpfl2nQ
Find out more about the DTA:
https://dtxalliance.org/
Twitter: https://twitter.com/dtx_alliance
LinkedIn: https://www.linkedin.com/company/dtxa...
32 episodes
Share
